baber/WOPTO huggingface dataset:
Patent NZ-554110-A (NZ)
Title: Apparatus for and method of forming concrete and transferring loads between concrete slabs
Inventor: MCDONALD STEPHEN F
Filed: 2005-09-28
Abstract: Methods and apparatus for forming concrete are disclosed, where a plate is left embedded in the concrete to discourage vertical movement between adjacent concrete slabs. The plate (300) has a first coated portion (320) and a second portion (315), and a form (200) is provided with a slot (260) configured to closely receive the second portion. The second portion is inserted into the slot and the form is positioned to receive the concrete. Concrete is poured on the form and the first portion, and then cured. The form is removed from the cured concrete, while the plate remains in place.
Patent NZ-555257-A (NZ)
Title: Spray gun having a passageway and a valve for controlling the flow of a gas or mixture of gases through the passageway
Inventor: ALEXANDER KEVIN L
IPC: B05B7/12
Filed: 2005-11-11
Abstract: A spray gun comprising a passageway and a valve for controlling the flow of a gas or mixture of gases through the passageway, is disclosed. The valve includes a valve stem and a valve body. The valve stem includes first threads and the valve body includes second threads where the first and second threads engage to permit adjustment of the valve stem with respect to the valve body selectively to adjust the flow through the passageway. The valve stem includes a plurality of notches and the valve body includes a ball yieldably urged into the notches where engagement of the ball and notches indicates the relative orientation of the valve stem and valve body.
Patent NZ-565765-A (NZ)
Title: Multiple chamber container
Inventor: TROUILLY JEAN LUC
IPC: B65D81/32
Filed: 2006-08-02
Abstract: A flexible container 10 for storing medical products comprising a) a plurality of adjacent chambers 12 14 16, comprising a first chamber 12 positioned at one lateral end of the container 10, a second chamber 16 positioned at an opposite lateral end of the container 10 and at least one additional middle chamber 14 positioned between the first and second chambers 12 16, b) a first frangible barrier 24 separating the first chamber 12 from the at least one additional middle chamber 14 and a second frangible barrier 22 separating the second chamber 16 from the at least one additional middle chamber 14, c) at least one port 26 28 30 located at one end of the container 10, each port 26 28 30 providing fluid communication with a different one of the first, second and at least one additional middle chambers 12 14 16, d) a flap defining outwardly curved borders of upper ends of the first chamber and second chamber and defining an inwardly curved border of an upper end of the additional middle chamber, and e) a longitudinal length of the at least one additional middle chamber being less than about three-quarters of at least one of a longitudinal length of the first and second chambers 12 16, whereby a fluid pressure may be selectively applied within one of the first and second chambers 12 16 to activate a respective one of the first and second frangible barriers 24 22 without activating the other one of the barriers.
Patent NZ-571520-A (NZ)
Title: Process of making polyisoprene condoms carried out at low temperature
Inventor: ATTRILL JULIE ANN
IPC: A61B19/04
Filed: 2007-03-12
Abstract: Disclosed is a process for making a compounded synthetic polyisoprene latex suitable for making a latex film, which process comprises: (a) compounding a synthetic polyisoprene latex with suitable compounding ingredients (b) maturing the latex and optionally (c) storing the latex wherein steps (a), (b) and (c) if included are carried out at a temperature of less than 20 degrees C so as to minimise prevulcanisation of the latex. Also disclosed are synthetic polyisoprene condoms.
Patent NZ-574311-A (NZ)
Title: Dimeric iap antagonists
Inventor: CONDON STEPHEN M
IPC: C12N5/09
Filed: 2007-07-24
Abstract: Disclosed is Bis(3-OH-pyrrolidino)-dipeptides of formula (I) where the substituents are as disclosed in the specification. Also disclosed is the use of a compound of formula (I) for the manufacture of a medicament. The medicament can be used for treating apoptosis in a cell, neoplastic cells, inhibit caspase, treat cancer, enhancing apoptosis of pathogenic cells regulating IAP. Further disclosed is a composition comprising a compound of formula (I).
Patent NZ-574697-A (NZ)
Title: Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same
Inventor: KIM JI DUCK
IPC: C07D401/14
Filed: 2007-07-11
Abstract: Disclosed are biaryl benzoimidazole derivatives of general formula (I) wherein the variables are defined in the specification for treating pain, acute pain, chronic pain, neuropathic pain, postoperative pain, migraine, arthralgia, neuropathies, nerve injury, diabetic neuropathy, neurological illness, neurodermatitis, stroke, bladder hypersensitivity, irritable bowel syndrome, cough, asthma, chronic obstructive pulmonary disease, burning, psoriasis, itching, vomiting, irritation of the skin, eyes, and mucous membranes, gastric-duodenal ulcers, inflammatory intestinal diseases, and inflammatory diseases.
Patent NZ-575692-A (NZ)
Title: Inhibitors of Serine Proteases, Particularly Hepatitis C Virus NS3-NS4 Protease
Inventor: PITLIK JANOS
IPC: A61P37/02
Filed: 2003-04-11
Abstract: Disclosed is a compound of formula (II) wherein X 1 is ûN(R20)-, -O-, -S-, or -C(RÆ)2-; X2 is ûC(O)-, -C(S)-, -S(O)-, or ûS(O)2-; and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of the above compound in the manufacture of a medicament for treating an HCV infection.
Patent NZ-577831-A (NZ)
Title: Handling anchor comprising a head and two opposing zig-zag body portions suitable for embedding in a concrete structure
Inventor: ARTEON MARCEL
IPC: E04C5/12
Filed: 2006-12-22
Abstract: 577831 Disclosed is a handling anchor, intended to be placed within a building component and of the type comprising a head for hooking up the building component to a handling machine, and a body including active portions. The handling anchor has a first anchor element extending substantially in a first direction. The first anchor element includes a head portion and a body portion integral with and extending from the head portion in the first direction. The body portion includes active portions which, is use provide adhesion of the anchor to the material of the building component. The body portion includes at least one transverse bend, a first generally planar active facet located beyond the bend and remote from the head in the first direction, and a second generally planar active facet located beyond the first generally planar active facet in the first direction so that the first generally planar active facet is located between the head and the second generally planar active facet. The first and second generally planar active facets extend from the head portion in the first direction in a zigzag pattern. The handling anchor has a second anchor element including a head portion and a body portion inversely bent relative to the body portion of the first anchor element. The head portions of the first and second anchor elements are joined to each other and the body portions of the first and second anchor elements are in contact with each other at respective bends.
Patent NZ-580058-A (NZ)
Title: A machine for forming a beverage where the water heater is turned off before the water is emptied out of the reservoir
Inventor: BRUDEVOLD FINN
IPC: A47J31/32
Filed: 2007-09-07
Abstract: A beverage forming machine is disclosed. The machine comprises a brew chamber (1) for receiving a beverage cartridge, a reservoir (5) for receiving precursor liquid for use in forming a beverage, a brew indication switch (91) for receiving an indication from a user to begin a brewing cycle, a heater (94) for heating precursor liquid in the reservoir, a detector (93) for detecting a desired temperature of precursor liquid in the reservoir, an air pump (92) for providing pressurized air to the reservoir and a controller (9) constructed and arranged to control operation of the heater (94) and the air pump (92). The controller (9) is adapted to control the heater (94) to heat the precursor liquid and cause the air pump (92) to deliver pressurized air to the reservoir (5) in response to the detector (93) detecting that the precursor liquid is at the desired temperature. (62) Divided Out of 575941
Patent NZ-581380-A (NZ)
Title: A neural response system to generate biomarker data
Inventor: LITHGOW BRIAN JOHN
IPC: A61B5/04
Filed: 2008-05-30
Abstract: A neural response system, including a plurality of filters (512, 514, 516) for each receiving and filtering a plurality of tilt response signals obtained from a person; a segmenter (550) for segmenting the filtered response signals into time segments; and a neural event extractor for performing a neural event extraction process on each of the time segments to obtain and generate biomarker data representing a plurality of biomarkers for each segment.
Patent NZ-585676-A (NZ)
Title: Apparatus for delivery of fibrous material
Inventor: DONNELLY WILLIAM JAMES
IPC: B29C53/78
Filed: 2005-04-29
Abstract: A rotating, multi-chamber element 160 for an apparatus 111 delivering a gas stream carrying loose fibrous material, with each chamber 166 of the element 160 moving between a first location where the chamber 166 is charged with the loose fibrous material by a gas stream carrying loose fibrous material and moving in one direction, and a second location where another gas stream moving in the opposite direction removes the loose fibrous material from the chamber 166. (62) Divided Out of 551704
Patent NZ-588429-A (NZ)
Title: Non-hydrating plaster composition and method
Inventor: YEUNG LEE K
IPC: C09D121/02
Filed: 2009-03-26
Abstract: Disclosed is a coated panel comprising: a building panel; and a coating comprising calcium sulfate hemihydrate in a latex polymer matrix, and a dual component set preventer distributed throughout said matrix, wherein said set preventer comprises at least one of the group consisting of low molecular weight polymers having a molecular weight less than 6,000 Daltons, compounds of polyphosphonic acid or esters thereof and mixtures thereof and wherein said low molecular weight polymers are selected from a group consisting of a polymer having a polyamide backbone, a polymer having a carboxylate functional group, a polymer made from vinyl acrylate, a monomer selected from the group consisting of , a vinyl chloride monomer, a styrene, substituted styrene, a substituted ethylene, or combinations thereof.
Patent NZ-594887-A (NZ)
Title: Use of synthetic and biological fungicides in combination for controlling harmful fungi
Inventor: HADEN EGON
IPC: A01N63/22
Filed: 2010-03-25
Abstract: 594887 Disclosed herein is the combined use of synthetic fungicides such as boscalid, metrafenone or dithianon and the biological control agent Bacillus subtilis for controlling harmful fungi. To be more precise, disclosed is a method for controlling harmful fungi, which comprises at least two treatment blocks, where in at least one treatment block the plants are treated with at least one synthetic fungicide and in at least one treatment block the plants are treated with at least one biological control agent, with the proviso that the last treatment block comprises subjecting the plants to at least one treatment with at least one biological control agent.
Patent NZ-600356-A (NZ)
Title: Fire protection sprinkler support system
Inventor: FEENSTRA SHAWN J
IPC: A62C31/28
Filed: 2012-05-31
Abstract: The support system 10 is for supporting a fire protection sprinkler adapter 22 and has a support bar 16 with end brackets and a centre bracket assembly 20 with a hinge pin 32 to connect halves 28, 30 of the bracket assembly so as to define an opening to receive a sprinkler adapter 22 on the other side of the bar from the hinge pin 32.
Patent NZ-604464-A (NZ)
Title: Anti-vegf antibodies and uses thereof
Inventor: CROY LESLIE A
IPC: C07K16/00
Filed: 2011-06-14
Abstract: 604464 Discloses a VEGF antibody comprising CDR H1: GYSLTYYGMN, CDR H2: WINTFTGDSTYAQDFT, CDR H3: YPHYYGSSHWYFDV and CDR L1: RASQSVNSNLA, CDR L2: GASTRAT and CDR H3: QQYSDIPWT and the use of said antibody as a medicament.
Patent NZ-623046-A (NZ)
Title: Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies
Inventor: ESPOSITO LUKE
IPC: A61K31/522
Filed: 2012-10-10
Abstract: Compounds comprising a caffeine core (1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione) molecule substituted with two phenyl groups which in turn are substituted with two hydroxyl groups each and their pharmaceutically acceptable salts for treatment of β-amyloid diseases, such as observed in Alzheimer’s disease and synucleinopathies, such as Parkinson’s disease. Alternative the compound can be described as xanthine core (3,7-dihydro-purine-2,6-dione) substituted with benzyl groups which in turn are substituted with two hydroxyl groups each.
Patent NZ-628900-A (NZ)
Title: Heavy fossil hydrocarbon conversion and upgrading using radio-frequency or microwave energy
Inventor: STROHM JAMES J
IPC: C10G15/08
Filed: 2012-11-20
Abstract: Disclosed is a method for the conversion of heavy fossil hydrocarbons (HFH) to a variety of value-added chemicals and/or fuels using microwave (MW) and/or radio-frequency (RF) energy comprising: flowing a continuous feed comprising HFH and a process gas through a reaction zone having a pressure greater than 0.9 atm; contacting the HFH and a HFH-to-liquids catalyst in at least the reaction zone; concentrating MW or RF energy in the reaction zone using a microwave or RF energy source; and generating dielectric discharges within the reaction zone; wherein the HFH and the catalyst have a residence time in the reaction zone of less than 30 seconds.
Patent NZ-628923-A (NZ)
Title: Targeted binding agents against b7-h1
Inventor: MULGREW KATHLEEN ANN
IPC: C07K16/28
Filed: 2010-11-24
Abstract: Disclosed is an isolated antibody that specifically binds to B7-H1 having an amino acid sequence comprising: a VH CDR1 having the amino acid sequence of TYSMN; and a VH CDR2 having the amino acid sequence of SISSSGDYIYYADSVKG; and a VH CDR3 having the amino acid sequence of DLVTSMVAFDY; and a VL CDR1 having the amino acid sequence of SGDALPQKYVF; and a VL CDR2 having the amino acid sequence of EDSKRPS; and a VL CDR3 having the amino acid sequence of YSTDRSGNHRV.
Patent NZ-708182-A (NZ)
Title: Bispecific t cell activating antigen binding molecules
Inventor: KLEIN CHRISTIAN
IPC: C07K16/30
Filed: 2014-02-24
Abstract: The present disclosure generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present disclosure relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The disclosure further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease. In particular, the invention provides a T cell activating bispecific antigen binding molecule comprising (i) a first antigen binding moiety which is a Fab molecule capable of specific binding to CD3, comprising the heavy chain complementarity determining region (CDR) 1 of SEQ ID NO: 4, the heavy chain CDR 2 of SEQ ID NO: 5, the heavy chain CDR 3 of SEQ ID NO: 6, the light chain CDR 1 of SEQ ID NO: 8, the light chain CDR 2 of SEQ ID NO: 9 and the light chain CDR 3 of SEQ ID NO: 10, wherein the first antigen binding moiety is a crossover Fab molecule wherein either the variable or the constant regions, particularly the constant regions, of the Fab light chain and the Fab heavy chain are exchanged; (ii) a second and a third antigen binding moiety each of which is a Fab molecule capable of specific binding to CEA comprising the heavy chain CDR 1 of SEQ ID NO: 24, the heavy chain CDR 2 of SEQ ID NO: 25, the heavy chain CDR 3 of SEQ ID NO: 26, the light chain CDR 1 of SEQ ID NO: 28, the light chain CDR 2 of SEQ ID NO: 29 and the light chain CDR3 of SEQ ID NO: 30; (iii) an Fc domain composed of a first and a second subunit capable of stable association, wherein the second antigen binding moiety is fused at the C-terminus of the Fab heavy chain to the N-terminus of the Fab heavy chain of the first antigen binding moiety, and the first antigen binding moiety is fused at the C-terminus of the Fab heavy chain to the N-terminus of the first subunit of the Fc domain, and wherein the third antigen binding moiety is fused at the C-terminus of the Fab heavy chain to the N-terminus of the second subunit of the Fc domain.
Patent NZ-712245-A (NZ)
Title: Wind park and method for controlling a wind park
Inventor: BEEKMANN ALFRED
IPC: F03D7/04
Filed: 2014-04-09
Abstract: A wind park is provided having a central wind park control unit (200), a plurality of wind turbines (100) and a data bus (210, 220) for coupling said central wind park control unit (200) to the plurality of wind turbines (100). Each of the wind turbines (100) has a control unit (120) which is designed to control the operation of the wind turbine (100) independently of the central wind park control unit (200) if an error occurs in the central wind park control unit (200) and/or an error occurs in the data bus (210, 220). The control unit (120) is designed to switch off the respective wind turbines (100) one after the other.
Patent NZ-712382-A (NZ)
Title: Flexible loop applicator and method
Inventor: KUEHL CRAIG
IPC: B65C9/08
Filed: 2014-05-01
Abstract: A tag applicator for applying a tag to a product disclosed herein generally addresses the problems associated with placing small items onto the packaging of a product. The tag has an elastic loop connected to a certain point on the tag, the tag applicator comprising: a linear actuator having a movable portion and a stationary portion; a pair of tag arms, one end of each being pivotably connected to and moving with the movable portion of the linear actuator; a single spring biasing the two arms toward each other; a separator, positioned between the tag arms and which is mounted so as not to be movable with respect to the stationary portion of the linear actuator, so as to force the tag arms to separate as the linear actuator extends; and a finger connected to each tag arm, configured and positioned to connect to the elastic loop, and to extend the elastic loop as the tag arms are separated so as to form the loop into a triangle, with the corners of the triangle being formed by the two fingers and the certain point on the tag, and into which triangle the product is moved in order to apply the tag to the product.
Patent NZ-712515-A (NZ)
Title: Inverter device
Inventor: IWAMATSU YUSUKE
IPC: H02M7/5395
Filed: 2014-03-10
Abstract: The purpose of the present invention is to effectively supply reactive electric power by controlling an output current even when there is a phase difference between the output current and the output voltage in an inverter device (1). For this purpose, the inverter device (1) is provided with an inverter section (2) constituted by a bridge circuit. A clamp section (5) is provided between two connection lines (S11, S12), which is constituted by a series circuit wherein a fifth switch element (Q5) having a fifth diode (D5) connected in inverse parallel, and a sixth switch element (Q6) having a sixth diode (D6) connected in inverse parallel are serially connected such that the conduction directions of the fifth diode and the sixth diode are opposite each other. A control unit (6) is provided to apply a pulse signal to the first switch element (Q1) through sixth switch element (Q6) for switching the elements on and off.
Patent NZ-713984-A (NZ)
Title: Pharmaceutical compositions comprising sorbitan esters
Inventor: HICKEY MAGALI B
IPC: C07D295/088
Filed: 2012-03-19
Abstract: Disclosed is an injectable pharmaceutical composition comprising: (a) a prodrug of olanzapine compound of formula (III) or (IV); (b) sorbitan laurate; (c) polysorbate 20; and (d) an aqueous vehicle (injectable carrier), for treating disorders of the central nervous system, including anxiety or depression, bipolar disorder, autism-related irritability, schizophrenia, schizophreniform diseases or a psychotic condition.
Patent NZ-716448-A (NZ)
Title: Combination of epigenetic factors and bispecific compounds targeting cd33 and cd3 in the treatment of myeloid leukemia
Inventor: WALTER ROLAND B
IPC: A61K39/395
Filed: 2014-09-15
Abstract: The present invention provides a combination epigenetic factors and bispecific compounds targeting CD33 and CD3 in the treatment of myeloid leukemia, wherein the epigenetic factor is hydroxyurea. Accordingly, the invention provides a pharmaceutical composition comprising a CD3 and CD33 targeting antibody construct and hydroxyurea for use in the amelioration and/or treatment of a myeloid leukemia, wherein the hydroxyurea increases the responsiveness of a patient to a CD3 and CD33 targeting antibody construct. Moreover, the invention provides the use of hydroxyurea in increasing the responsiveness of a myeloid leukemia patient to a treatment with a CD3 and CD33 targeting antibody construct, a method for the treatment of a myeloid leukemia, the method comprising the administration of hydroxyurea and a CD3 and CD33 targeting antibody construct to a patient in the need thereof and a kit comprising a pharmaceutical composition of hydroxyurea and a bispecific CD3 and CD33 targeting antibody construct.
Patent NZ-729628-A (NZ)
Title: Methods for the treatment of peri-implantitis
Inventor: EMANUEL NOAM
IPC: A61P19/08
Filed: 2015-09-27
Abstract: The present invention relates to pharmaceutical compositions comprising biocompatible bone augmentation material coated with a matrix composition the matrix composition comprising: (a) a biocompatible polymer; (b) a first lipid comprising at least one sterol; (c) a second lipid comprising at least one phospholipid having fatty acid moieties of at least 14 carbons; and (d) at least one antibiotic agent selected from doxycycline or doxycycline hyclate at 0.4-2% (w/w) of the total weight of the pharmaceutical composition, and their use in the preparation of medicaments for the treatment of peri-implant diseases, in particular peri-implantitis associated with the destruction of the crest of the alveolar bone supporting the implant. Specifically, the treatment comprises the step of applying the medicament to a peri-implant bone loss site after surgically exposing the dental implant in the peri-implant bone loss site and debriding and decontaminating the exposed dental implant.
Patent NZ-730736-A (NZ)
Title: A round baler
Inventor: VARLEY SEAMUS
IPC: A01F15/07
Filed: 2015-10-05
Abstract: The application discloses a round baler for forming a bale from a crop product. Prior art balers often suffer from extensive wear of rotating parts and housing components. To overcome or at least mitigate problems related to the prior art, a baler according to the invention comprises a first bale forming chamber provided with a first bale forming mechanism, a second bale forming chamber provided with a second bale forming mechanism, a working unit, comprising a rotor ro-tatable around a rotor axis of a cutting mechanism and / or feeding mechanism, a scraper unit, comprising a scraper working tool functionally assigned to the cutting mechanism and / or the feeding mechanism, and a transfer mechanism adapted to transfer a partially formed bale from the first bale forming chamber into the second bale forming chamber , wherein the scraper work-ing tool and the transfer working tool are movable on an arc of a circle the center of which is pro-vided by the rotor axis, such movement of the scraper working tool and the transfer working tool being decoupled from each other as well as from rotation of the rotor of the working unit. Ac-cording to the invention, the scraper unit and the transfer mechanism are allowed to rotate inde-pendently from the rotation of the rotor and are therefore not adding an additional rotational fric-tional load to the rotation of the feeding rotor.